Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162706 · ClinicalTrials.gov registry record
Salivary Cortisol Measurements by Mass Spectrometry
A clinical trial of Endocrine Disorders, sponsored by Stanford University.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT02162706 is a study of Endocrine Disorders that has completed, run by Stanford University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02162706, a study of Endocrine Disorders, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Cortisol is a hormone critical for survival in times of stress. Currently most measurements are done with blood samples. The hypothesis of this study is cortisol measured from saliva using mass spectrometry can be used to replace measurements by blood.
Conditions Studied
Interventions
- OTHER Non intervention study
Study Locations (1)
California
- Lucile Packard Children's Hospital and Stanford Clinics - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02162706
The ClinicalTrials.gov registry entry for NCT02162706 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endocrine Disorders appearing as the primary indexed condition, and to 1 intervention - of which Non intervention study is the first listed.
NCT02162706 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02162706 about?
NCT02162706 is a clinical study titled "Salivary Cortisol Measurements by Mass Spectrometry". Cortisol is a hormone critical for survival in times of stress. Currently most measurements are done with blood samples. The hypothesis of this study is cortisol measured from saliva using mass spectrometry can be used to replace measurements by blood.
What is the current status of trial NCT02162706?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-06. Estimated completion is 2016-03.
What conditions does trial NCT02162706 study?
This clinical trial studies the following conditions: Endocrine Disorders.
What interventions are being tested in trial NCT02162706?
The interventions under investigation include: Non intervention study (OTHER).
Who is sponsoring clinical trial NCT02162706?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02162706 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.